June 13, 2013 Synthetic Biologics to Host Multiple Sclerosis-Estriol Investor Day in New York City on June 25, 2013
April 19, 2013 Synthetic Biologics Reiterates that the Infectious Disease Collaboration with Intrexon Remains in Effect
April 4, 2013 Synthetic Biologics Announces Issuance of U.S. Patent Covering Combination of Estriol and Copaxone® for Multiple Sclerosis
February 26, 2013 Infectious Disease Specialist, Brad Spellberg, M.D., Joins Synthetic Biologics' Scientific Advisory Board
February 22, 2013 Synthetic Biologics Reports that Flupirtine Sublicensee, Meda AB, to Initiate Phase II Fibromyalgia Clinical Trial in U.S.
